September 09, 2020

Chinese Biotech Sector is Blowing Hot as M&A and IPO Deals Surge Amid Covid-19 Pandemic

Toto Ku, Datasite Senior Sales Director, provides comments on the outlook for the Chinese biotech sector, including the surge in M&A and IPO deals amid the COVID-19 pandemic. The South Morning China Post article highlights findings from a recent webinar discussion on Deal Drivers in the Healthcare and Life Sciences: Mainland China.

  • Datasite for Healthcare

    Navigating the healthcare and life sciences industry has never been harder. Whether you’re looking at a licensing, listing or M&A, achieve your objective quickly and keep sensitive data secure with Datasite.

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

651.632.4009

[email protected]

You may also like:

Cybersecurity in a Digital World and the War For Talent

EMEA CRO Merlin Piscitelli writes about cybersecurity and the war for talent in a digital world, citing data from Datasite's survey of 200 senior UK M&A professionals.

The ‘S’ in ESG’s Impact on M&A & How to Mitigate Risks

CEO Rusty Wiley writes about the impact social factors can have on dealmaking and how to mitigate some of the risks.

Global Banking & Finance Review
Cybersecurity in a Digital World and the War For Talent

Sophisticated cyberwarfare and rising geopolitical tensions mean that cybersecurity threats are evolving at a very rapid pace, impacting entire businesses operations and their hard-won reputations. EMEA CRO Merlin Piscitelli writes about cybersecurity and the war for talent in a digital world.

Benzinga